SNP and gene associations use P < 10⁻¹⁰. Change threshold · Counts cover features with indexed GWAS data; — means unavailable.

GeneAssociated metabolitesResearch resources

GENE DETAIL · Glycine max

Glyma.20G120200

Description hypothetical protein

Gene interval Chr20:36268998–36282456 (-), Wm82.a2.v1 · 1-based inclusive

Arabidopsis ortholog NA

Genome context

Explore gene–feature relationships using Overlap or Within ±5 kb. Scope definitions

Explore research resources ↓
Associated metabolite features692Overlap
Maximum supporting SNP records3
Features with ≥2 supporting SNP records244

Supporting SNP records satisfy P < 10⁻¹⁰ and the selected positional scope. Counts cover the 30345 features with indexed GWAS data.

Additional descriptive statistic

Mean supporting SNP records per associated feature: 1.3540.

Research resources

Follow this gene identifier to compare annotations, examine protein function and find supporting literature.

These links search the displayed identifier. Check the organism, genome assembly and evidence in the destination record.

Compare gene models, expression and reported orthologs

SoyBase gene-name translator ↗SoyBase expression resources ↗Legume Information System ↗

Use expression and ortholog evidence to develop a testable hypothesis. The linked resources do not establish the function of this soybean gene in the measured samples.

Associated metabolites

Browse associated features and open their GWAS evidence or compound candidates.

692 matching features · page 58 of 70

Metabolite IDCandidate annotationDeionized mass (Da)Supporting SNP recordsMinimum P
P36912 Rhodojaponin IV 454.2533 19.071e-11
P37074 Ankalactone 338.1703 17.248e-11
P37338 Quadranoside X 650.3972 15.733e-11
P37496 Galangin 5-methyl ether 284.0675 18.227e-11
P37584 Desmethylsibutramine 265.1624 12.921e-11
P37674 Blebbistatin 292.1218 14.036e-11
P37745 Altromycin I 693.2714 13.384e-11
P38105 Gentirigenic acid 522.3508 14.946e-12
P38204 Acacetin 7-[3'''-(2-methylbutyryl)rutinoside] 676.2396 18.711e-12
P38256 Ibritumomab tiuxetan 569.2320 12.911e-11